You are here

  • Home
  • Archive
  • Volume 2, Issue Suppl 3
  • Preliminary results of the Phase IIa trial of a folate binding protein (FBP) adjuvant cancer vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence

Citation Tools

Article menu

Download PDFPDF

Poster Presentation
Preliminary results of the Phase IIa trial of a folate binding protein (FBP) adjuvant cancer vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Greene J, Schneble E, Berry J, et al
Preliminary results of the Phase IIa trial of a folate binding protein (FBP) adjuvant cancer vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence
Journal for ImmunoTherapy of Cancer 2014;2:P74. doi: 10.1186/2051-1426-2-S3-P74